Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 2333917.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied eight patients who had visual field defects secondary to prolactin-secreting macroadenomas and who had improved visual function with bromocriptine treatment without surgery or radiation. We recommend bromocriptine as a primary treatment for prolactin-secreting macroadenomas. If therapy is effective, continued regular neuro-ophthalmologic, endocrine, and imaging studies are necessary, because treatment with bromocriptine must be continued indefinitely.
Medical subject headings
- Bromocriptine
- Pituitary Neoplasms
- Prolactinoma
- Vision, Ocular